Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)
Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy, safety and pharmacodynamic markers of the study drug,
A6, in patients with CLL and small lymphocytic lymphoma (SLL).